340B Advocacy Alliance Bulletin
Urge your representatives to sign letter to HHS asking it to take action to protect providers from ‘devastating’ J&J 340B proposal; deadline is Sept. 20.
The Health Resources and Services Administration today told Johnson & Johnson that the company’s publicly announced plans to implement a 340B rebate model “violates J&J’s obligations under the 340B statute, and HRSA expects J&J to cease implementation of it.”
The AHA, 340B Health and the American Society of Health-System Pharmacists last week filed an amicus brief in a federal district court in Missouri, defending the state's law protecting 340B pricing for contract pharmacy arrangements.
If Johnson & Johnson moves forward with its plan to undermine the 340B Drug Pricing Program by unilaterally imposing a rebate model rather than the longstanding upfront discount model, the Health Resources and Services Administration should take “immediate enforcement action,” including…
J&J announces major change to 340B pricing; HRSA responds to preemptive AHA advocacy.
The Health Resources and Services Administration Aug. 7 requested public comment on how petitioners file initial claims in the 340B Administrative Dispute Resolution process and how it affects stakeholders’ administrative load.
As the annual 340B hospital recertification period approaches, the Health Resources and Services Administration’s Office of Pharmacy Affairs is hosting a certification webinar on Wednesday, Aug. 7 from 1-2 p.m. ET.
AHA, others file briefs in Maryland, West Virginia to prevent injunctions against 340B pricing for contract pharmacy arrangements
A Mississippi judge yesterday denied Novartis Pharmaceuticals’ and PhRMA’s request for a preliminary injunction against enforcement of state law protecting 340B pricing for contract pharmacy arrangements.
The AHA, 340B Health, the Maryland Hospital Association and the Mid-Atlantic Association of Community Health Centers yesterday filed an amicus brief in a federal district court in Maryland, defending the state's law protecting 340B pricing for contract pharmacy arrangements.